CPC A61K 31/05 (2013.01) [A61K 9/006 (2013.01); A61K 31/22 (2013.01); A61K 31/352 (2013.01); A61K 31/366 (2013.01); A61K 31/405 (2013.01); A61K 31/47 (2013.01); A61K 31/505 (2013.01); A61K 36/185 (2013.01); A61P 9/10 (2018.01); A61P 21/00 (2018.01)] | 20 Claims |
1. A pharmaceutical composition for once daily dosing, useful in enhancing the bioavailability upon oral administration to a human patient of a statin, comprising:
(a) a reduced daily dosage amount of the statin; and
(b) a phytocannabinoid;
wherein the pharmaceutical composition is formulated for oral administration, and wherein the reduced daily dosage amount of the statin is less than the standard daily dosage amount for the statin when taken alone.
|